Individualize dosing based on disease severity and patient response:
DO NOT BREAK OR USE PARTIAL PREDNISOLONE SODIUM PHOSPHATE ORALLY DISINTEGRATING TABLETS. USE AN APPROPRIATE FORMULATION OF PREDNISOLONE IF INDICATED DOSE CANNOT BE OBTAINED USING PREDNISOLONE SODIUM PHOSPHATE ORALLY DISINTEGRATING TABLETS.
drug label
Orapred prescribing information
Need to report an Orapred issue?
ONLINE FORMReport adverse event
Learn More
You can report a Orapred adverse event on MedWatch, the FDA's medical product safety reporting program for health professionals, patients and consumers.
Can't find what you're looking for?
Our trained staff can help you:
Please note:
Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.